On December 23, 2025, Aspira Women's Health Inc. entered into a purchase agreement with Lincoln Park Capital Fund to sell up to $10 million of its common stock over the next 24 months, allowing targeted sales based on market conditions. This event is significant as it enhances capital access for the company.